心身疗法用于频繁就诊的医学无法解释症状患者:CORPUS随机对照试验研究方案
CORPUS试验是一项在初级保健中开展的随机有效性试验,计划纳入158名18岁及以上频繁因医学无法解释症状(MUS)就诊于全科医生的患者,比较在常规照护基础上加用由专业心身运动治疗师提供的心身疗法与仅常规照护的效果。心身疗法为多组分个体化干预,包含心理教育、放松技术、正念、认知方法和分级活动,共6至12次、每次30至45分钟。主要结局为患者特异性功能与失能(PSFS),并将在基线、4个月和12个月评估,同时进行经济学评价和混合方法过程评价。
要点
- 心身疗法由专业心身运动治疗师提供,为多组分个体化干预,共6至12次、每次30至45分钟。
- 主要结局为患者特异性功能与失能,采用患者特异性功能量表(PSFS)测量。
- 试验同时评估症状严重度、就诊频率、转诊、满意度、生活质量与成本,并进行经济学评价。
核心结论
- 研究旨在明确由专业心身运动治疗师提供的心身疗法对频繁因MUS就诊全科医生的患者是否具有成本效果,能否减轻症状并改善功能。
研究设计与样本
- 随机有效性试验,在初级保健中开展,计划纳入158名18岁及以上频繁因MUS就诊全科医生的患者。
- 患者被分配至常规照护加心身疗法组或仅常规照护组。
- 评估在基线、4个月和12个月进行,并附经济学评价(社会视角,QALYs为结局指标)和混合方法过程评价。
关键数值与推荐
- 心身疗法为多组分个体化干预,应用心理教育、放松技术、正念、认知方法和/或分级活动。
- 心身疗法组接受6至12次治疗,每次30至45分钟,由专业运动或物理治疗师提供。
- 主要结局为患者特异性功能与失能,采用PSFS测量;次要结局包括症状严重度、就诊频率、二级照护转诊、患者满意度、生活质量和成本。
临床怎么用
- 为频繁因MUS就诊全科医生的患者,在常规照护基础上可考虑加用由专业治疗师提供的心身疗法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Medically unexplained symptoms (MUS) are highly prevalent and pose a burden both on patients and on health care. In a pilot study psychosomatic therapy delivered by specialised therapists for patients with MUS showed promising results with regard to patient's acceptability, feasibility and effects on symptoms. The aim of this study is to establish whether psychosomatic therapy by specialised psychosomatic exercise therapists is cost- effective in decreasing symptoms and improving functioning in patients who frequently consult their general practitioner (GP) with MUS. METHODS: A randomised effectiveness trial with an economic evaluation in primary care with 158 patients aged 18 years and older who are frequently consulting their GP with MUS. Patients will be assigned to psychosomatic therapy in addition to usual care or usual care only. Psychosomatic therapy is a multi-component and tailored intervention, aiming to empower patients by applying psycho-education, relaxation techniques, mindfulness, cognitive approaches and/or graded activity. Patients assigned to the psychosomatic therapy receive 6 to 12 sessions of psychosomatic therapy, of 30-45 min each, delivered by a specialised exercise or physical therapist. Primary outcome measure is patient-specific functioning and disability, measured with the Patient-Specific Functional Scale (PSFS). Secondary outcome measures are symptom severity, consultation frequency and referrals to secondary care, patient satisfaction, quality of life and costs. Assessments will be carried out at baseline, and after 4 and 12 months. An economic evaluation alongside the trial will be conducted from a societal perspective, with quality-adjusted life years (QALYs) as outcome measure. Furthermore, a mixed-methods process evaluation will be conducted. DISCUSSION: We expect that psychosomatic therapy in primary care for patients who frequently attend the GP for MUS will improve symptoms and daily functioning and disability, while reducing consultation frequency and referrals to secondary care. We expect that the psychosomatic therapy provides value for money for patients with MUS. TRIAL REGISTRATION: Netherlands Trial Register, ID: NL7157 (NTR7356). Registered 13 July 2018.
引用
- Wortman MSH, van der Wouden JC, Grutters JPC, et al. Psychosomatic therapy for patients frequently attending primary care with medically unexplained symptoms, the CORPUS trial: study protocol for a randomised controlled trial. Trials. 2019. PMID: 31818310. doi:10.1186/s13063-019-3913-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。